Avidity Biosciences Inc. - ADR

Name: Avidity Biosciences Inc. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Avidity Biosciences Inc. - ADR

Stock Card

$13.32

$-0.32 (-2.35%)

As on 31-Aug-2026 16:00EDT

Market cap

$233 Mln

Revenue (TTM)

$36 Mln

P/E Ratio

P/B Ratio

1.1

Div. Yield

0 %

Avidity Biosciences - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 13.10 High: 13.55

52 Week Range

Low: 11.13 High: 73.06

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.4 %
ROCE

-- %
Industry P/E

37.32
EV/EBITDA

-5.7
Debt to Equity

0
Book Value

$--
EPS

$-6.2
Face value

--
Shares outstanding

17,105,643

6 Years Aggregate

CFO

$-394.43 Mln

EBITDA

$-599.44 Mln

Net Profit

$-586.70 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Avidity Biosciences - ADR	-81.5	16.2	2.5	-71.4	18.7	-8.6	--
BSE Sensex^*	-9.1	-1.5	2.9	-3.6	5.9	6.0	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 31-Aug-2026 | *As on 01-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021
Avidity Biosciences - ADR	148.0	218.3	-59.2	-6.6	-6.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3
BSE Sensex	9.1	8.1	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Avidity Biosciences - ADR	13.3	233.3	36.0	-259.3	-727.6	-122.9	--	1.1
Amneal Pharmaceuticals Inc Class A (AMRX)	17.5	6,109.1	3,117.6	157.4	14.7	--	37.3	190.1
Axsome Therapeutics (AXSM)	198.5	10,424.8	776.6	-191.6	-17.6	-223.4	--	129.6
BridgeBio Pharma (BBIO)	76.6	14,974.8	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	113.4	12,310.3	830.8	54.9	3.2	8.1	264.8	17.9
Dr. Reddy's Laboratories - ADR	12.1	10,087.6	332,834.2	33,166.6	11.1	8.9	28.8	2.5
Elanco Animal Health (ELAN)	23.9	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Ligand Pharmaceuticals (LGND)	284.1	5,591.7	290.5	197.2	82.5	19.9	28.9	5.9
Liquidia Technologies Inc (LQDA)	68.2	6,058.9	450.9	138.6	39.1	115.6	50.1	32.1
Twist Bioscience Corp (TWST)	139.0	8,865.6	431.8	-136.7	-30.8	-30.3	--	21.5

Shareholding Pattern

View Details

About Avidity Biosciences - ADR

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include... ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. It has a research collaboration and license agreement with Bristol-Myers Squibb Company and Eli Lilly and Company. The company was incorporated in 2025 and is headquartered in San Diego, California. Read more

Co-Founder & Chairman

Dr. Troy Edward Wilson J.D., Ph.D.
Co-Founder & Chairman

Dr. Troy Edward Wilson J.D., Ph.D.
Headquarters

San Diego, CA
Website

https://atriumtherapeutics.com

FAQs for Avidity Biosciences - ADR

What is the current share price of Avidity Biosciences Inc - ADR Today?

The share price of Avidity Biosciences Inc - ADR is $13.32 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Avidity Biosciences Inc - ADR has given a return of 18.67% in the last 3 years.

What is the current PB & PE ratio of Avidity Biosciences Inc - ADR?

Since, TTM earnings of Avidity Biosciences Inc - ADR is negative, P/E ratio is not available.
The P/B ratio of Avidity Biosciences Inc - ADR is 1.11 times as on 28-Aug-2026, a 86 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-16.10	5.96
2024	-11.59	2.62
2023	-3.24	1.37
2022	-7.52	2.20
2021	-4.78	1.47

What is the 52 Week High and Low of Avidity Biosciences Inc - ADR?

The 52-week high and low of Avidity Biosciences Inc - ADR are Rs 73.06 and Rs 11.13 as of 01-Sep-2026.

What is the market cap of Avidity Biosciences Inc - ADR?

Avidity Biosciences Inc - ADR has a market capitalisation of $ 233 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Avidity Biosciences Inc - ADR?

Before investing in Avidity Biosciences Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.